N42.31
Prostatic intraepithelial neoplasia
Clinical Classification Guidelines
Inclusion Terms
- PIN
- Prostatic intraepithelial neoplasia I (PIN I)
- Prostatic intraepithelial neoplasia II (PIN II)
Excludes Type 1
- prostatic intraepithelial neoplasia III (PIN III) (D07.5)
Medical Intelligence & Overview
Prostatic intraepithelial neoplasia (PIN) is a condition affecting the prostate gland, which is part of the male reproductive system. It involves abnormal growth of the prostate cells, but unlike prostate cancer, PIN itself is not cancerous. However, it is considered a precursor lesion, meaning it has the potential to develop into prostate cancer over time. Recognizing and understanding PIN is important for monitoring prostate health and guiding appropriate medical follow-up.
Causes & Symptoms
Clinical Causes: Genetic factors and family history of prostate cancer Hormonal changes, particularly in testosterone levels Age-related changes in prostate tissue, commonly affecting men over 50 Lifestyle factors such as diet, obesity, and smoking may influence risk, though their roles are less defined
Key Symptoms: PIN typically does not cause noticeable symptoms It is often found incidentally during prostate biopsies or examinations for other issues In some cases, men might experience signs similar to benign prostatic hyperplasia (BPH), such as difficulty urinating, but these are not directly caused by PIN
Diagnostic & Treatment
Diagnosis Path: PIN is usually diagnosed through tissue examination following a prostate biopsy. When abnormal cells are identified in the prostate tissue samples, pathologists classify the degree of PIN, which can be noted as PIN I (mild), PIN II (moderate), or PIN III (severe). The process involves microscopic analysis by trained professionals to differentiate PIN from other prostate conditions, including prostate cancer.
Treatment Protocols: Since PIN itself is not cancerous, active treatment may not always be necessary. Instead, management often involves careful monitoring, which can include regular prostate-specific antigen (PSA) tests and repeat biopsies to observe any changes over time. In some cases, if other prostate abnormalities are present, clinicians might recommend specific interventions or lifestyle modifications to support prostate health.
Clinical Advice & FAQs
Billing Guidance
Is N42.31 a billable ICD-10 code?
Yes, N42.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N42.31?
Clinical documentation must specify the nature of Prostatic intraepithelial neoplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference